Anti-CD137 mAb treatment inhibits experimental autoimmune uveitis by limiting expansion and increasing apoptotic death of uveitogenic T cells.

Source:http://linkedlifedata.com/resource/pubmed/id/15671287

Download in:

View as

General Info

PMID
15671287